About
Robocath is a French medical technology company founded in 2009 and based in Rouen, France. The company specializes in designing and developing robotic solutions for treating cardiovascular diseases, employing over 70 people. Its flagship product, R-One™, is a robotic system that assists in coronary angioplasty procedures, enhancing the precision and safety of these critical interventions. R-One™ features unique bionic technology that replicates and optimizes the physician's hand movements, ensuring compatibility with leading devices and catheterization laboratories. The system received CE marking in 2019 after demonstrating high technical success rates in clinical trials. It is currently utilized in Europe, Africa, and China, and it also helps reduce healthcare workers' exposure to harmful X-rays during procedures. Robocath aims to be a leader in vascular robotics, focusing on developing smart, connected solutions that improve procedural safety and enable remote interventions. The company is committed to enhancing access to vascular emergency treatments worldwide.
Technologies
Keywords
Company Information
-
Employees 50
-
Founded 2009
-
Annual Revenue $120000000
-
Total Funding $57261427
Location
19 Rue Marie Curie, Rouen, Upper Normandy, France, 76000